References
- McLaughlin M, Patrizio P, Kayisli U, et al. mTOR kinase inhibition results in oocyte loss characterized by empty follicles in human ovarian cortical strips cultured in vitro. Fertil Steril 2011;96:1154–9e1.
- Reddy P, Liu L, Adhikari D, et al. Oocyte-specific deletion of Pten causes premature activation of the primordial follicle pool. Science 2008;319:611–3.
- Castrillon DH, Miao L, Kollipara R, et al. Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science 2003;301:215–8.
- Kawamura K, Cheng Y, Suzuki N, et al. Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment. Proc Natl Acad Sci USA 2013;110:17474–9.
- Skinner MK. Regulation of primordial follicle assembly and development. Hum Reprod Update 2005;11:461–71.
- Durlinger AL, Gruijters MJ, Kramer P, et al. Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology 2002;143:1076–84.
- Jeppesen JV, Anderson RA, Kelsey TW, et al. Which follicles make the most anti-Mullerian hormone in humans? Evidence for an abrupt decline in AMH production at the time of follicle selection. Mol Hum Reprod 2013;19:519–27.
- Knight PG, Satchell L, Glister C. Intra-ovarian roles of activins and inhibins. Mol Cell Endocrinol 2012;359:53–65.
- Gilchrist RB, Lane M, Thompson JG. Oocyte-secreted factors: regulators of cumulus cell function and oocyte quality. Hum Reprod Update 2008;14:159–77.
- Albertini DF, Combelles CM, Benecchi E, et al. Cellular basis for paracrine regulation of ovarian follicle development. Reproduction 2001;121:647–53.
- Hsieh M, Lee D, Panigone S, et al. Luteinizing hormone-dependent activation of the epidermal growth factor network is essential for ovulation. Mol Cell Biol 2007;27:1914–24.
- Scaramuzzi RJ, Baird DT, Campbell BK, et al. Regulation of folliculogenesis and the determination of ovulation rate in ruminants. Reprod Fertil Dev 2011;23:444–67.
- Baird DT. A model for follicular selection and ovulation: lessons from superovulation. J Steroid Biochem 1987;27: 15–23.
- Hanna CB, Hennebold JD. Ovarian germline stem cells: an unlimited source of oocytes? Fertil Steril 2014;101:20–30
- Hansen KR, Hodnett GM, Knowlton N, et al. Correlation of ovarian reserve tests with histologically determined primordial follicle number. Fertil Steril 2011;95:170–5.
- van Dorp W, van den Heuvel-Eibrink MM, de Vries AC, et al. Decreased serum anti-Mullerian hormone levels in girls with newly diagnosed cancer. Hum Reprod 2014;29: 337–42.
- Dewailly D, Gronier H, Poncelet E, et al. Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. Hum Reprod 2011;26:3123–9.
- Dewailly D, Andersen CY, Balen A, et al. The physiology and clinical utility of anti-Mullerian hormone in women. Hum Reprod Update 2014;20:370–385. doi: 10.1093/humupd/dmt062 [Epub ahead of print]
- Freeman EW, Sammel MD, Lin H, et al. Anti-Mullerian hormone as a predictor of time to menopause in late reproductive age women. J Clin Endocrinol Metab 2012;97:1673–80.
- Kristensen SG, Andersen K, Clement CA, et al. Expression of TGF-beta superfamily growth factors, their receptors, the associated SMADs and antagonists in five isolated size-matched populations of pre-antral follicles from normal human ovaries. Mol Hum Reprod 2014;20:293–308.